Minority enrollment in Parkinson’s Disease clinical trials: meta-analysis and systematic review of studies evaluating treatment of neuropsychiatric symptoms. (2104)

Daniel G. Di Luca(University of Miami), Corneliu Luca(University of Miami Health System), Jacob A Sambursky(University of Miami), Jason Margolesky(University of Miami), Joacir Graciolli Cordeiro(University of Miami), Carlos Singer(University of Miami Health System), Anthony Diaz(University of Miami), Danielle S. Shpiner(University of Miami)

Neurology

April 14, 2020

10.1212/wnl.94.15_supplement.2104

Cited by 0

Related Papers

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease

|JAMA|2016|397

Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

|Sleep Medicine|2013|391

Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy—a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group

|Sleep Medicine|2013|238

Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study

|The Lancet Neurology|2020|155

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease

|Neurology|2016|137